🇺🇸 15-Valent Pneumococcal Conjugate Vaccine in United States

15-Valent Pneumococcal Conjugate Vaccine (15-Valent Pneumococcal Conjugate Vaccine) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

15-Valent Pneumococcal Conjugate Vaccine in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is 15-Valent Pneumococcal Conjugate Vaccine approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for 15-Valent Pneumococcal Conjugate Vaccine in United States?

Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.